Debios Diagnostics was challenged by Tim Juergens to sharpen its strategy and value-creation roadmap.
Public source
Publisher name
Public post
Tim Juergens and I have known each other for several years, but had never had the opportunity to work together. What better occasion than the EIT Health Catapult (and a…
Company
Debios Diagnostics
Redefining kidney care with non-invasive fibrosis diagnostics
- Industry
- Biotechnology Research
- Location
- Badalona, ES
- Company size
- 2–10 employees
About Debios Diagnostics
Debios is a spin-off from the Barcelona-based hospital research institute IGTP, developing non-invasive diagnostic solutions to improve kidney health. Its lead product, FIBROKIT®, is a urine-based test for the assessment of renal fibrosis, designed to support earlier clinical action and monitoring in chronic kidney disease and kidney transplantation.
See moreLatest activity
Latest activity from Debios Diagnostics
3 signals
Discover more
Similar signals
Similar public activity from other companies.
Partnerships
BioCrossroads
BioCrossroads supported the AXIS program built on the MIT Venture Mentoring Service model and supported by its partners.
Partnerships
Euroimmun
Euroimmun integrated IDS service teams into its customer service organisation, consolidating processes, sharing knowledge, and creating new structures.
Partnerships
BioLabs Rochester MN
BioLabs Rochester MN was established through a collaboration among BioLabs, Mayo Clinic, Destination Medical Center (DMC), and Mortenson.
Partnerships
TSI Group
TSI Group collaborated with Emily to continue developing science-driven solutions for healthier lives.
Partnerships
NJ Bio, Inc.